Press Releases

Imvax Announces Completion of $29 Million Financing and...

– Financing funds operations into 2026 – – Company on track to report top-line ...

Aro Biotherapeutics Doses First Patient in Phase 1b Tri...

Trial aims to establish safety and provide proof of concept for GYS1 inhibition ...

XyloCor Therapeutics Raises $67.5 Million in Series B F...

Financing round led by new investor Jeito Capital with participation from existi...

Avacta Appoints Brian Hahn as Chief Financial Officer

Brian brings 25 years’ senior financial and operational experience, including le...

Every Cure Expands Collaboration with Google Cloud to T...

Every Cure will leverage Google Cloud’s infrastructure and AI technologies, incl...

Adaptimmune Announces U.S. FDA Breakthrough Therapy Des...

The Company will present at the Annual J.P. Morgan Healthcare Conference, provid...

Institute of Molecular and Clinical Ophthalmology Basel...

Funding enables progress of RhyGaze lead asset through early clinical trials Le...

GEMMABio Appoints Dr. May Orfali as Chief Medical Officer

Experienced medical executive brings expansive knowledge in clinical development...

$28.5M Revitalization of 3711 Market Street at uCity Sq...

Renovation will increase lab capacity and provide turnkey lab suites in Philadel...